Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing

FDA Comment Number :

EC367

Submitter :

Mr. Peter Vilinsky

Date & Time:

12/09/2005 11:12:30

Organization :

Mr. Peter Vilinsky

Category :

Individual Consumer

Issue Areas/Comments

GENERAL

GENERAL

I think that the FDA should regulate this. In particular advertizing for SSRI class drugs and Ritalin type treatments for ADHD should be prohibited since the ads promote chemical imbalances of the brain for which there is no substantiated, empiracle proof. And these drugs are found to be harmful. They should be taken off the market altogether, let alone be advertized.